КАЧЕСТВО ЖИЗНИ ПАЦИЕНТОВ С ПРОЛАПСОМ МИТРАЛЬНОГО КЛАПАНА
Patients with mitral valve prolapse (MVP) revealed a significant deterioration in the quality of life (QOL) compared with healthy people. After a course of the Magnerot, alprazolam (Xanax), psychotherapy significantly improve was estimated. In observing these same patients after 15 years recorded a...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
SINAPS LLC,
2013-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Patients with mitral valve prolapse (MVP) revealed a significant deterioration in the quality of life (QOL) compared with healthy people. After a course of the Magnerot, alprazolam (Xanax), psychotherapy significantly improve was estimated. In observing these same patients after 15 years recorded a decline in all QOL parameters compared to the results immediately after treatment and from baseline. However, patients with MVP who regularly used Magnerot over the years found a significant improvement of quality of life. |
|---|---|
| Item Description: | 2226-6704 2411-6564 10.20514/2226-6704-2013-0-2-22-28 |